Organization | CPR Pharma Services Pty Ltd, Australia

CPR Pharma Services Pty Ltd, Australia Report issue

For profit Phase 1

Founded: Adelaide Australia (2008)

Organization Overview

First Clinical Trial

2010

NCT01222949

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

CPR Pharma Services Pty Ltd, Australia

Active Ingredients

Drugs in Phase 1 Trials (13)

bnc101 (1 trial)

ctx-4430 (1 trial)

entecavir (baraclude) (2 trials)

ep7041 (1 trial)

eurartesim (2 trials)

eyp001a (2 trials)

fluorouracil (efudex) (1 trial)

interferon alpha-2a (roferon-a) (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (1 trial)

mannitol (1 trial)

spr741 (1 trial)

tebipenem (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Colorectal Neoplasms (Phase 1)

Hepatitis B (Phase 1)

Hepatitis B, Chronic (Phase 1)

Inflammation (Phase 1)

Malaria, Falciparum (Phase 1)

Pneumonia (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 9
# of Trial APIs: 13